APA (7th ed.) Citation

XQ, T., XW, N., HL, X., L, Z., DL, Z., B, C., . . . YZ, Z. (2017). Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction. Dove Medical Press.

Chicago Style (17th ed.) Citation

XQ, Tian, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, Lu CT, Yuan JJ, and Zhao YZ. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.

MLA (8th ed.) Citation

XQ, Tian, et al. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.